Inventor
CHAN CHUN KONG LAVAL
CA22 patents
⚠️ This page may combine multiple inventors who share the name “CHAN CHUN KONG LAVAL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VIROCHEM PHARMA INC
8 patentsUS6881741B2Apr 19, 2005
Compounds and methods for the treatment or prevention of Flavivirus infections
VIROCHEM PHARMA INC107 citations96
US6936629B2Aug 30, 2005
Compounds and methods for the treatment or prevention of flavivirus infections
VIROCHEM PHARMA INC51 citations91
US6887877B2May 3, 2005
Compounds and methods for the treatment or prevention of Flavivirus infections
VIROCHEM PHARMA INC45 citations91
US7569600B2Aug 4, 2009
Compounds and methods for the treatment of prevention of Flavivirus infections
VIROCHEM PHARMA INC34 citations90
US7402608B2Jul 22, 2008
Compounds and methods for the treatment or prevention of Flavivirus infections
VIROCHEM PHARMA INC37 citations90
US7960403B2Jun 14, 2011
Spirotropane compounds and methods for the modulation of chemokine receptor activity
VIROCHEM PHARMA INC4 citations60
US7288548B2Oct 30, 2007
Spiro compounds and methods for the modulation of chemokine receptor activity
VIROCHEM PHARMA INC4 citations60
US7709642B2May 4, 2010
Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
VIROCHEM PHARMA INC0 citations40
CHAN CHUN KONG LAVAL
4 patentsUS8658674B2Feb 25, 2014
Thiophene analogues for the treatment or prevention of flavivirus infections
CHAN CHUN KONG LAVAL0 citations48
US8269014B2Sep 18, 2012
Thiophene analogues for the treatment or prevention of flavivirus infections
CHAN CHUN KONG LAVAL0 citations48
US8329924B2Dec 11, 2012
Compounds and methods for the treatment or prevention of Flavivirus infections
CHAN CHUN KONG LAVAL0 citations38
US8076349B2Dec 13, 2011
Spirotropane compounds and methods for the modulation of chemokine receptor activity
CHAN CHUN KONG LAVAL0 citations38
VERTEX PHARMA
3 patentsUS7985769B2Jul 26, 2011
Compounds and methods for the treatment or prevention of Flavivirus infections
VERTEX PHARMA6 citations72
US8779156B2Jul 15, 2014
Analogues for the treatment or prevention of flavivirus infections
VERTEX PHARMA7 citations70
US8765731B2Jul 1, 2014
Benzimidazole analogues for the treatment or prevention of flavivirus infections
VERTEX PHARMA1 citations50
VERTEX PHARMACEUTICALS CANADA INC
3 patentsUS8003685B2Aug 23, 2011
Thiophene analogues for the treatment or prevention of flavivirus infections
VERTEX PHARMACEUTICALS CANADA INC1 citations59
US8357718B2Jan 22, 2013
Compounds and methods for the treatment or prevention of flavivirus infections
VERTEX PHARMACEUTICALS CANADA INC2 citations57
US8829030B2Sep 9, 2014
Compounds and methods for the treatment or prevention of Flavivirus infections
VERTEX PHARMACEUTICALS CANADA INC0 citations45